Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    June 2018
  1. SCHLEISS MR
    Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protection.
    Proc Natl Acad Sci U S A. 2018 Jun 6. pii: 1806420115.
    PubMed     Text format    


    May 2018
  2. TZENG SY, McHugh KJ, Behrens AM, Rose S, et al
    Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response.
    Proc Natl Acad Sci U S A. 2018 May 21. pii: 1720970115.
    PubMed     Text format     Abstract available


    April 2018
  3. SAH P, Medlock J, Fitzpatrick MC, Singer BH, et al
    Optimizing the impact of low-efficacy influenza vaccines.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1802479115.
    PubMed     Text format     Abstract available


  4. NELSON CS, Huffman T, Jenks JA, Cisneros de la Rosa E, et al
    HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1800177115.
    PubMed     Text format     Abstract available


  5. BARANIAK I, Kropff B, Ambrose L, McIntosh M, et al
    Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1800224115.
    PubMed     Text format     Abstract available


    March 2018
  6. OBOLSKI U, Lourenco J, Thompson C, Thompson R, et al
    Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae.
    Proc Natl Acad Sci U S A. 2018 Mar 6. pii: 1718712115.
    PubMed     Text format     Abstract available


    January 2018
  7. VERMA AA, Jimenez MP, Tangermann RH, Subramanian SV, et al
    Insecurity, polio vaccination rates, and polio incidence in northwest Pakistan.
    Proc Natl Acad Sci U S A. 2018 Jan 29. pii: 1711923115.
    PubMed     Text format     Abstract available


    December 2017
  8. RAYMOND DD, Bajic G, Ferdman J, Suphaphiphat P, et al
    Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1715471115.
    PubMed     Text format     Abstract available


  9. PANANOS AD, Bury TM, Wang C, Schonfeld J, et al
    Critical dynamics in population vaccinating behavior.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1704093114.
    PubMed     Text format     Abstract available


  10. WEISBERG AS, Maruri-Avidal L, Bisht H, Hansen BT, et al
    Enigmatic origin of the poxvirus membrane from the endoplasmic reticulum shown by 3D imaging of vaccinia virus assembly mutants.
    Proc Natl Acad Sci U S A. 2017 Dec 4. pii: 1716255114.
    PubMed     Text format     Abstract available


    November 2017
  11. ZOST SJ, Parkhouse K, Gumina ME, Kim K, et al
    Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Proc Natl Acad Sci U S A. 2017 Nov 6. pii: 201712377.
    PubMed     Text format     Abstract available


    October 2017
  12. KOEHLER H, Cotsmire S, Langland J, Kibler KV, et al
    Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3.
    Proc Natl Acad Sci U S A. 2017;114:11506-11511.
    PubMed     Text format     Abstract available


  13. BUSTAMANTE LY, Powell GT, Lin YC, Macklin MD, et al
    Synergistic malaria vaccine combinations identified by systematic antigen screening.
    Proc Natl Acad Sci U S A. 2017 Oct 23. pii: 201702944.
    PubMed     Text format     Abstract available


  14. LISBOA MP, Khan N, Martin C, Xu FF, et al
    Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5.
    Proc Natl Acad Sci U S A. 2017 Oct 2. pii: 201706875.
    PubMed     Text format     Abstract available


    September 2017
  15. MAAMARY J, Wang TT, Tan GS, Palese P, et al
    Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201707950.
    PubMed     Text format     Abstract available


    June 2017
  16. ALOE C, Kulldorff M, Bloom BR
    Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States.
    Proc Natl Acad Sci U S A. 2017 Jun 20. pii: 201700240.
    PubMed     Text format     Abstract available


    May 2017
  17. PIZZOLLA A, Wang Z, Groom JR, Kedzierska K, et al
    Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells.
    Proc Natl Acad Sci U S A. 2017 May 1. pii: 201620194.
    PubMed     Text format     Abstract available


    April 2017
  18. MARCHIO S, Bansal P, Pasqualini R, Arap W, et al
    An antivascular vaccine to boost self-immunity and strike the tumor.
    Proc Natl Acad Sci U S A. 2017 Apr 11. pii: 201701452.
    PubMed     Text format    


  19. ORENSTEIN WA, Ahmed R
    Simply put: Vaccination saves lives.
    Proc Natl Acad Sci U S A. 2017 Apr 10. pii: 201704507.
    PubMed     Text format    


    March 2017
  20. MEDLOCK J, Pandey A, Parpia AS, Tang A, et al
    Effectiveness of UNAIDS targets and HIV vaccination across 127 countries.
    Proc Natl Acad Sci U S A. 2017 Mar 20. pii: 201620788.
    PubMed     Text format     Abstract available


    February 2017
  21. LYKE KE, Ishizuka AS, Berry AA, Chakravarty S, et al
    Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
    Proc Natl Acad Sci U S A. 2017 Feb 21. pii: 201615324.
    PubMed     Text format     Abstract available


  22. KAZMIN D, Nakaya HI, Lee EK, Johnson MJ, et al
    Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.
    Proc Natl Acad Sci U S A. 2017 Feb 13. pii: 201621489.
    PubMed     Text format     Abstract available


  23. BRUHN CA, Hetterich S, Schuck-Paim C, Kurum E, et al
    Estimating the population-level impact of vaccines using synthetic controls.
    Proc Natl Acad Sci U S A. 2017 Feb 1. pii: 201612833.
    PubMed     Text format     Abstract available


    January 2017
  24. CAMPEOTTO I, Goldenzweig A, Davey J, Barfod L, et al
    One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen.
    Proc Natl Acad Sci U S A. 2017 Jan 17. pii: 201616903.
    PubMed     Text format     Abstract available


  25. LE NOUEN C, McCarty T, Brown M, Smith ML, et al
    Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure.
    Proc Natl Acad Sci U S A. 2017 Jan 3. pii: 201619242.
    PubMed     Text format     Abstract available


    December 2016
  26. WU CY, Lin CW, Tsai TI, Lee CD, et al
    Influenza A surface glycosylation and vaccine design.
    Proc Natl Acad Sci U S A. 2016 Dec 27. pii: 201617174.
    PubMed     Text format     Abstract available


  27. PING J, Lopes TJ, Neumann G, Kawaoka Y, et al
    Development of high-yield influenza B virus vaccine viruses.
    Proc Natl Acad Sci U S A. 2016 Dec 5. pii: 201616530.
    PubMed     Text format     Abstract available


    November 2016
  28. MIKE LA, Smith SN, Sumner CA, Eaton KA, et al
    Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection.
    Proc Natl Acad Sci U S A. 2016 Nov 7. pii: 201606324.
    PubMed     Text format     Abstract available


    October 2016
  29. YAMIN D, Jones FK, DeVincenzo JP, Gertler S, et al
    Vaccination strategies against respiratory syncytial virus.
    Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201522597.
    PubMed     Text format     Abstract available


  30. PIERCE BG, Keck ZY, Lau P, Fauvelle C, et al
    Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine design.
    Proc Natl Acad Sci U S A. 2016 Oct 26. pii: 201614942.
    PubMed     Text format     Abstract available


  31. WENTINK MQ, Hackeng TM, Tabruyn SP, Puijk WC, et al
    Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.
    Proc Natl Acad Sci U S A. 2016 Oct 17. pii: 201610258.
    PubMed     Text format     Abstract available


  32. TAM HH, Melo MB, Kang M, Pelet JM, et al
    Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination.
    Proc Natl Acad Sci U S A. 2016 Oct 4. pii: 201606050.
    PubMed     Text format     Abstract available


    August 2016
  33. EARL LA, Subramaniam S
    Cryo-EM of viruses and vaccine design.
    Proc Natl Acad Sci U S A. 2016 Aug 1. pii: 201609721.
    PubMed     Text format    


    June 2016

  34. Retraction for Zhang et al., Stabilization of vaccines and antibiotics in silk and eliminating the cold chain.
    Proc Natl Acad Sci U S A. 2016 Jun 20. pii: 201608261.
    PubMed     Text format    


  35. BAKKER KM, Martinez-Bakker ME, Helm B, Stevenson TJ, et al
    Digital epidemiology reveals global childhood disease seasonality and the effects of immunization.
    Proc Natl Acad Sci U S A. 2016;113:6689-94.
    PubMed     Text format     Abstract available


  36. LI Y, Hill A, Beitelshees M, Shao S, et al
    Directed vaccination against pneumococcal disease.
    Proc Natl Acad Sci U S A. 2016 Jun 6. pii: 201603007.
    PubMed     Text format     Abstract available


    May 2016
  37. REBER SO, Siebler PH, Donner NC, Morton JT, et al
    Immunization with a heat-killed preparation of the environmental bacterium Mycobacterium vaccae promotes stress resilience in mice.
    Proc Natl Acad Sci U S A. 2016;113:E3130-9.
    PubMed     Text format     Abstract available


  38. CHEN E, Salinas ND, Huang Y, Ntumngia F, et al
    Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.
    Proc Natl Acad Sci U S A. 2016 May 18. pii: 201600488.
    PubMed     Text format     Abstract available


    March 2016
  39. DEL TORDELLO E, Danilchanka O, McCluskey AJ, Mekalanos JJ, et al
    Type VI secretion system sheaths as nanoparticles for antigen display.
    Proc Natl Acad Sci U S A. 2016;113:3042-7.
    PubMed     Text format     Abstract available


  40. BIAGINI M, Spinsanti M, De Angelis G, Tomei S, et al
    Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined.
    Proc Natl Acad Sci U S A. 2016;113:2714-9.
    PubMed     Text format     Abstract available


  41. NEHER RA, Bedford T, Daniels RS, Russell CA, et al
    Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses.
    Proc Natl Acad Sci U S A. 2016 Mar 7. pii: 201525578.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: